| LRP engineered nanolipidic carriers as potential therapeutics for brain targeting in Wilson's disease | Life Sciences & Biotechnology | 2023 | 2025 |
| synthesis and evaluation of novel dual GsK-3β/HDAC inhibitor as an anti-Alzheimer agent | Life Sciences & Biotechnology | 2023 | 2026 |
| Development of micro-RNA (miRNA) responsive gene expression platforms for targeting Breast Cancer | Life Sciences & Biotechnology | 2023 | 2026 |
| Understanding the impact of drug-herbal dietary supplements pharmacokinetic interactions: Integrated transcriptomics analysis to study the key metabolism, pathways, and safety evaluation | Life Sciences & Biotechnology | 2023 | 2026 |
| Ex Vivo and In vivo Evaluation of Novel Therapeutic Regimen of the Cyclin Dependent Kinase 4/6 Inhibitors loaded Hybrid lipid-polymeric Nanoparticles Against Triple-negative Breast Cancer | Life Sciences & Biotechnology | 2024 | 2027 |
| Design and development of a non-invasive controlled release sol-gel based- dual drug delivery system for simultaneous alleviation of intraocular pressure and retinal ganglionic cells degeneration in glaucoma | Life Sciences & Biotechnology | 2024 | 2026 |
| Elucidating role of cellular senescence in immunological aging in dendritic cells and its modulation through nutritional immunotherapy interventions | Life Sciences & Biotechnology | 2024 | 2026 |
| Endocannabinoids for cognitive aging and neurodegeneration | Life Sciences & Biotechnology | 2023 | 2023 |
| Alpha V Beta 3 Integrin Aspired Vesicular Nanohybrids Based Neoadjuvant Therapy for Locally Advanced Colon Cancer | Life Sciences & Biotechnology | 2023 | 2025 |
| Molecular explorations of the Leishmania donovani Homoserine Dehydrogenase and evaluating the impact of its perturbations using CRIsPR-Cas9 system' | Life Sciences & Biotechnology | 2023 | 2026 |